In the Boardroom
Refine Search
Biotechnology
US biotech Paragon Therapeutics yesterday revealed that biotech industry veteran Susanna High has been appointed as chief executive (CEO). In this newly-created role, Ms High will lead the team’s continued efforts to propel the development of a pipeline of transformative therapies and accelerate their potential impact. 22 November 2024
Biotechnology
US biotech major Amgen has announced that Dr Howard Chang will join the company as senior vice president of research, effective December 16, 2024. 21 November 2024
Pharmaceutical
Anthony Harnden has been appointed as the new chair of the UK’s Medicine and Healthcare products Regulatory Agency (MHRA). 20 November 2024
Biotechnology
Mirai Bio has announced the appointment of Jens Vogel as the company’s president and chief operating officer (COO). 20 November 2024
Biotechnology
Aclaris Therapeutics has announced an exclusive licensing agreement with Biosion for broad rights to two new antibodies. 19 November 2024
Biotechnology
Privately-held US biotech Georgiamune has announced the appointment of Mark Avagliano as chief business officer (CBO). 19 November 2024
Pharmaceutical
New York-based Mind Medicine, a company developing MM120, a form of LSD (lysergide d-tartrate), for mental health conditions, has announced the appointment of Gregg Pratt, as chief regulatory and quality assurance officer. 19 November 2024
Biotechnology
Belgian biotech start-up ExeVir Bio says it has appointed Michael Garrett as its new chief executive (CEO), effective 1 December 2024. 18 November 2024
Biotechnology
ALX Oncology Holdings, a Californian immuno-oncology company, has announced the appointment of Alan Sandler as chief medical officer (CMO). 14 November 2024
Pharmaceutical
US ophthalmology specialist Ocular Therapeutix announced that Namrata Saroj has joined the Company on a full-time basis as chief business officer (CBO). Dr Saroj previously served as development strategy consultant to Ocular since February 2024. 14 November 2024
Biotechnology
VarmX, a Dutch biotech developing innovative approaches for the bypass of direct oral anticoagulants targeting activated factor Xa (FXa DOACs) and inherited coagulation disorders, has appointed industry veteran John Glasspool (pictured, above) as chief executive. 12 November 2024
Biotechnology
French biotech DiogenX, which is focused on regenerating insulin-producing beta cells for the treatment of diabetes, today announces the appointment of Dr Klara Owen as chief medical officer. 12 November 2024
Biotechnology
Rubedo Life Sciences, a US biopharma developing first-in-class therapies targeting senescent cells which drive age-related diseases, has announced the appointment of Frederick C Beddingfield III, as chief executive officer and board director. 11 November 2024
Biotechnology
US clinical-stage drug developer Acumen Pharmaceuticals has appointed Amy Schacterle as chief regulatory officer and head of quality, reporting to Jim Doherty, president and chief development officer at Acumen. 7 November 2024
Biotechnology
Memo Therapeutics, a privately-held Swiss biotech company translating unique responses into superior medicines to treat viral infections and cancer, has appointed a new chief development officer (CDO). 4 November 2024
Biotechnology
Netherlands-based Tessellate BIO, a pre-clinical stage biotech with a focus on novel synthetic lethality approaches, today announced the appointment of Dr Lara Boyd as chief business officer. 4 November 2024
Biotechnology
US biotech major Biogen revealed it has appointed Daniel Quirk as chief medical officer and head of medical affairs. 29 October 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Biotechnology
AAVantgarde has announced the appointment of Lauren Kaskiel as chief business officer (CBO). 22 October 2024
Biotechnology
David-Alexandre “DA” Gros has joined Neurocrine Biosciences as president and chief operating officer, the American biotech group announced today. 6 January 2017
Biotechnology
Biotech firm Sobi have announced the recruitment of Armin Reininger as senior vice president and head of global medical and scientific affairs. 5 January 2017
Biotechnology
US-based biotech firm Gilead has recruited Alessandro Riva as senior vice president of hematology and oncology. Dr Riva helped develop more than 20 cancer compounds as head of oncology at Swiss giant Novartis, including both targeted and immune-oncology treatments. 4 January 2017
Biotechnology
Ireland-headquartered Shire has announced the appointment of Ian Clark as a non-executive director of the company with effect from today (January 3). 3 January 2017
Pharmaceutical
Provectus Biopharmaceuticals has said that, on December 27, 2016, its board of directors unanimously voted to terminate Peter Culpepper, effective immediately, from all positions held with the company, including chief executive and chief operating officer. 30 December 2016
Pharmaceutical
US fertility treatment specialist OvaScience lost nearly a third of its value after it announced major workforce cuts and the departure of two top executives. 22 December 2016
Pharmaceutical
News that AstraZeneca was losing the experienced head of one its focus areas caused a slight share price wobble on Monday – but the company is confident that his shoes will be ably filled. 21 December 2016
Biotechnology
The share price of AstraZeneca has suffered a further hit this week with the news that it is to lose its head of oncology. 20 December 2016
Biotechnology
US biotech major Biogen has now selected a new chief executive to replace outgoing incumbent George Scangos, who has led the company since 2010 but announced his intention to leave last year, from its own ranks. 20 December 2016
Biotechnology
Genentech, the US-based biotech unit of Swiss pharma giant Roche, has announced its new chief executive after the retirement of Ian Clark. 16 December 2016
Pharmaceutical
Troubled Valeant Pharmaceuticals has announced the departure of three executives, as the business continues to restructure at the close of a punishing 2016. 14 December 2016
Biotechnology
Shares of US biotech firm Alexion Pharmaceuticals plunged as much as 15.6% to $111.44 on Monday, after it was revealed that its chief executive David Hallal had resigned for personal reasons, and chief financial officer Vikas Sinha was leaving to pursue other opportunities. 13 December 2016
Pharmaceutical
Effective February 1, 2017, Robert LaCaze will become executive vice president of the new Oncology Strategic Business unit at the Pharmaceuticals Division of German pharma major Bayer. 13 December 2016
Pharmaceutical
A new man is at the helm of the European Federation of Pharmaceutical Industries and Association (EFPIA) after the departure of Richard Bergström. 12 December 2016
Pharmaceutical
French pharma company Ipsen today announced that Claude Bertrand, executive vice president, R&D, chief scientific officer, will depart Ipsen on January, 2017, to join another company. 12 December 2016
Pharmaceutical
Lisa Anson, president of AstraZeneca UK and Ireland, has been elected as the next president of trade group the Association of the British Pharmaceutical Industry (ABPI). 7 December 2016
Generics
Israel’s Teva Pharmaceutical Industries says that Dipankar Bhattacharjee has been appointed president and chief executive, Global Generic Medicines Group, effective Monday. 6 December 2016
Pharmaceutical
After seven years as chief executive of ViiV Healthcare, Dr Dominique Limet will step down at the end of March 2017. 5 December 2016
Biotechnology
Last week, US biotech major Gilead Sciences terminated its licensing deal with GlobeImmune to develop a hepatitis-B (HBV) drug, GS-4774, and returned rights to the drug. 22 November 2016
Pharmaceutical
Experienced industry executive Hervé Gisserot is to become head of pharmaceuticals for the newly-created Asia Pacific Region at UK pharma major GlaxoSmithKline. 22 November 2016
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze